In a demonstration of the booming field of genomic research, investors have pumped $21.3 million into a company that makes and manufactures genome-wide research tools and services.
OriGene Technologies said its Series C was led by Chinese venture firm Qiming Venture Partners and Kleiner Perkins Caufield Byers China, with participation from previous investor IDG-Accel, a China-focused private equity firm.
{iframe}http://medcitynews.com/2013/03/genomics-research-supplier-rounds-up-21-3-million-from-china-focused-investors/{/iframe}